Disparities in timely access to COVID-19 therapeutics

Here we summarise the key findings and recommendations from the UK COVID-19 inquiry and the report ‘Beyond the pandemic: Addressing disparities in timely access to COVID-19 therapeutics Policy Report (July 2025)*.   *This report was commissioned and wholly funded by Pfizer but independently authored by Kintiga. It has been reviewed by Pfizer to ensure ABPI Code